Literature DB >> 16879169

alpha-Melanocyte-stimulating hormone and oxytocin: a peptide signalling cascade in the hypothalamus.

N Sabatier1.   

Abstract

alpha-Melanocyte-stimulating hormone (alpha-MSH) and oxytocin share remarkable similarities of effects on behaviour in rats; in particular, they both inhibit feeding behaviour and stimulate sexual behaviour. Recently, we showed that alpha-MSH interacts with the magnocellular oxytocin system in the supraoptic nucleus; alpha-MSH induces the release of oxytocin from the dendrites of magnocellular neurones but it inhibits the secretion of oxytocin from their nerve terminals in the posterior pituitary. This effect of alpha-MSH on supraoptic nucleus oxytocin neurones is remarkable for two reasons. First, it illustrates the capacity of magnocellular neurones to differentially regulate peptide release from dendrites and axons and, second, it emphasises the putative role of magnocellular neurones as a major source of central oxytocin release, and as a likely substrate of some oxytocin-mediated behaviours. The ability of peptides to differentially control secretion from different compartments of their targets indicates one way by which peptide signals might have a particularly significant effect on neuronal circuitry. This suggests a possible explanation for the striking way in which some peptides can influence specific, complex behaviours.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879169     DOI: 10.1111/j.1365-2826.2006.01464.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  23 in total

1.  Genetic modulation of oxytocin's effects in social functioning.

Authors:  Huiping Huang; Francesco Papaleo
Journal:  Ann Transl Med       Date:  2015-12

Review 2.  The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings.

Authors:  David M Cochran; Daniel Fallon; Michael Hill; Jean A Frazier
Journal:  Harv Rev Psychiatry       Date:  2013 Sep-Oct       Impact factor: 3.732

3.  Annexin A1 complex mediates oxytocin vesicle transport.

Authors:  V Makani; R Sultana; K S Sie; D Orjiako; M Tatangelo; A Dowling; J Cai; W Pierce; D A Butterfield; J Hill; J Park
Journal:  J Neuroendocrinol       Date:  2013-12       Impact factor: 3.627

Review 4.  Species, sex and individual differences in the vasotocin/vasopressin system: relationship to neurochemical signaling in the social behavior neural network.

Authors:  H Elliott Albers
Journal:  Front Neuroendocrinol       Date:  2014-08-04       Impact factor: 8.606

Review 5.  The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies.

Authors:  Meera E Modi; Larry J Young
Journal:  Horm Behav       Date:  2011-12-20       Impact factor: 3.587

Review 6.  The contribution of brain reward circuits to the obesity epidemic.

Authors:  Eric Stice; Dianne P Figlewicz; Blake A Gosnell; Allen S Levine; Wayne E Pratt
Journal:  Neurosci Biobehav Rev       Date:  2012-12-10       Impact factor: 8.989

7.  Neonatal melanocortin receptor agonist treatment reduces play fighting and promotes adult attachment in prairie voles in a sex-dependent manner.

Authors:  Catherine E Barrett; Meera E Modi; Billy C Zhang; Hasse Walum; Kiyoshi Inoue; Larry J Young
Journal:  Neuropharmacology       Date:  2014-06-09       Impact factor: 5.250

Review 8.  Functional consequences of neuropeptide and small-molecule co-transmission.

Authors:  Michael P Nusbaum; Dawn M Blitz; Eve Marder
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

9.  Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice.

Authors:  Bassil M Kublaoui; Terry Gemelli; Kristen P Tolson; Yu Wang; Andrew R Zinn
Journal:  Mol Endocrinol       Date:  2008-05-01

10.  Attenuated hypothalamic responses to α-melanocyte stimulating hormone during pregnancy in the rat.

Authors:  S R Ladyman; R A Augustine; E Scherf; H R Phillipps; C H Brown; D R Grattan
Journal:  J Physiol       Date:  2016-02-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.